Webinar Global Epidemiology; Research Update: Remdesivir and additional COVID Webinars
Wednesday, July 15, 2020 @ 3:00 PM ET
Global COVID-19 Epidemiology and Lessons Learned
from Lifting Mitigation Strategies
Research Update: Remdesivir
Speakers
Global COVID-19 Epidemiology and Lessons Learned from Lifting Mitigation Strategies
Benjamin A. Dahl, PhD, MPH
Deputy for Science, COVID-19 International Task Force, U.S. Centers for Disease Control and Prevention, Atlanta, GA
Deputy for Science on the CDC’s COVID-19 International Task Force, Dr. Benjamin Dahl, will present on the global epidemiology of COVID-19 and include metrics from mortality surveillance systems through innovative data visualizations. He will also present on the different global approaches to lifting mitigation strategies, with a focus on school re-openings, and highlight country case-studies from Europe.
Research Update: Remdesivir
Matthew Davis, PharmD
Infectious Diseases Pharmacist, UCLA Ronald Reagan Medical Center, Los Angeles, CA
UCLA Infectious Disease Pharmacist, Dr. Matthew Davis, will give a brief review of major trials that have studied Remdesivir as a treatment for COVID-19 and discuss the clinical takeaways.
Moderators
Paul Wax, MD, FACMT
Executive Director,
American College of Medical Toxicology
Charles McKay, MD, FACMT, FACEP
Past President, American College of Medical Toxicology